HIV Related Content
NIH grants supports HIV care and climate change research
Researchers aim to uncover how extreme weather affects long-term HIV care outcomes and implications for addressing climate change impacts and other chronic health conditions.
Researchers unravel HIV drug resistance mechanisms
The National Institutes of Health and Salk Institute researchers have made strides in understanding the molecular mechanisms behind HIV drug resistance mechanisms.
Living with HIV: The prevalent pandemic which is no longer considered a pandemic
Dr Avinash Hari Narayanan (MBChB), Clinical Lead at London Medical Laboratory, explains that we need stronger efforts worldwide to end HIV transmission and improve the lives of those living with the disease.
Why have HIV outcomes improved with urban gardening?
An urban gardening program has received $3.4 million to reduce food insecurity in the Dominican Republic – and was also found to greatly improve HIV outcomes.
HIV is more likely for women suffering from intimate partner violence
Women who experience recent intimate partner violence are three times more likely to contract HIV in regions like Sub-Saharan Africa.
The global picture of Tuberculosis: A view from WHO
Experts Dr Michel Gasana & Dr Frank Lule from World Health Organization – Regional Office for Africa, provide an update on the global picture of Tuberculosis.
Keeping up to date with the symptoms of monkeypox
There are important differences in the symptoms of monkeypox between the current outbreak and previous outbreaks in endemic regions.
Could cutting-edge technology provide a potential HIV cure?
Scientists at AIDS 2022 describe how new technological insights into HIV latent cells could help HIV cure research.
Lessons from the mouse model of cutaneous leishmaniasis
Peter Bretscher, from the University of Saskatchewan looks at whether mouse models of cutaneous leishmaniasis are pertinent for vaccination against and treatment of AIDS, infectious diseases, and cancer.
New treatment for cryptococcal meningitis in people living with HIV
The WHO have new treatment guidelines for cryptococcal meningitis in people living with HIV - a single high dose of liposomal amphotericin B.
First case of woman cured from HIV, after dual stem-cell transplant
The first ever woman cured from HIV underwent a dual stem-cell transplant, which seems to have made her genetically resistant to HIV and put her cancer into remission.
Global COVID-19 responses could help to end HIV
Global COVID-19 responses could serve as a coordinated approach to end the HIV pandemic - bettering global immunisation to both viruses.
Clinical trials begin for three mRNA HIV vaccines
The National Institute of Allergy and Infectious Diseases (NIAID) has launched Phase 1 clinical trials for three mRNA HIV vaccines.
The life-threatening perseverance of HIV stigma
The stigma, discrimination and lack of understanding around HIV is still persisting even 41 years after the first reported case
Researchers find ‘Hotspot’ for highly infectious diseases
Research published in BMJ Global Health has found a hotspot for HIV, tuberculosis and malaria in a regional corner of Africa.
Third known case of HIV remission after stem cell transplant
After receiving a cord blood stem cell transplant to treat acute myeloid leukaemia a woman with diagnosed HIV has had no detectable levels of HIV for 14 months
The key to safe sex education is understanding pleasure
Acknowledging pleasure as a key driver of sexual behaviour has more success in teaching safe sex than traditional sex education – as well as targeting STI/HIV risk reduction.
Tuberculosis prevention efforts in Africa
Dr Michel Gasana & Dr Hugues Lago from WHO - Regional Office for Africa, spoke to OAG about the status of tuberculosis prevention
Men who pay for sex 50% more likely to be living with HIV
A survey, conducted over 20 years in 35 African countries, suggests that one in ten sexually active men are 50% more likely to be living with HIV.
FDA approves new long-lasting drug for HIV prevention
December saw monumental steps being taken in HIV prevention with the FDA approving their first approval of long-acting HIV prevention medication.